NaDyF 4 nanoparticles as T 2 contrast agents for ultrahigh field magnetic resonance imaging

Journal of Physical Chemistry Letters

Volumn 3, Issue 4, 2012, Pages 524-529

  Das, Gautom Kumar ^a   Johnson, Noah J J ^a   Cramen, Jordan ^a   Blasiak, Barbara ^b   Latta, Peter ^b   Tomanek, Boguslaw ^b   Van Veggel, Frank C J M ^a  

^a UNIVERSITY OF VICTORIA   (Canada)

^b NATIONAL RESEARCH COUNCIL CANADA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST AGENT; FIELD STRENGTHS; MAGNETIC FIELD STRENGTHS; MR IMAGES; MRI CONTRAST AGENTS; MRI SCANNERS; RELAXIVITY; SPIN RELAXATION; ULTRAHIGH-FIELDS;

DYSPROSIUM; MAGNETIC FIELDS; MAGNETIC RESONANCE IMAGING;

NANOPARTICLES;

EID: 84857516316     PISSN: None     EISSN: 19487185     Source Type: Journal    
DOI: 10.1021/jz201664h     Document Type: Article

References (34)

1. Blow, N. Functional Neuroscience: How to Get Ahead in Imaging Nature 2009, 458, 925-928
2. Caravan, P. Strategies for Increasing the Sensitivity of Gadolinium Based MRI Contrast Agents Chem. Soc. Rev. 2006, 35, 512-523 (Pubitemid 43815285)
3. II-Containing Cryptates as Contrast Agents for Ultra-High Field Strength Magnetic Resonance Imaging Chem. Commun. 2011, 47, 12858-12860
4. Tsutomu, N. Clinical Application of High and Ultra High-Field MRI Brain Dev. 2007, 29, 325-335
5. Corot, C.; Robert, P.; Idée, J.-M.; Port, M. Recent Advances in Iron Oxide Nanocrystal Technology for Medical Imaging Adv. Drug Deliver. Rev. 2006, 58, 1471-1504 (Pubitemid 44820503)
6. Louie, A. Multimodality Imaging Probes: Design and Challenges Chem. Rev. 2010, 110, 3146-3195
7. Na, H. B.; Song, I. C.; Hyeon, T. Inorganic Nanoparticles for MRI Contrast Agents Adv. Mater. 2009, 21, 2133-2148
8. Gultepe, E.; Reynoso, F. J.; Jhaveri, A.; Kulkarni, P.; Nagesha, D.; Ferris, C.; Harisinghani, M.; Campbell, R. B.; Sridhar, S. Monitoring of Magnetic Targeting to Tumor Vasculature through MRI and Biodistribution Nanomedicine 2010, 5, 1173-1182
9. 2 Contrast Agent Adv. Mater. 2007, 19, 2411-2411
10. Helm, L. Optimization of Gadolinium-based MRI Contrast Agents for High Magnetic-Field Applications Future Med. Chem. 2010, 2, 385-396
11. Rosenberg, J. T.; Kogot, J. M.; Lovingood, D. D.; Strouse, G. F.; Grant, S. C. Intracellular Bimodal Nanoparticles Based on Quantum Dots for High-Field MRI at 21.1 T Magn. Reson. Med. 2010, 64, 871-882
12. Terreno, E.; Castelli, D. D.; Viale, A.; Aime, S. Challenges for Molecular Magnetic Resonance Imaging Chem. Rev. 2010, 110, 3019-3042
13. Viswanathan, S.; Kovacs, Z.; Green, K. N.; Ratnakar, S. J.; Sherry, A. D. Alternatives to Gadolinium-Based Metal Chelates for Magnetic Resonance Imaging Chem. Rev. 2010, 110, 2960-3018
14. 2 Contrast Agents: Preparation and Relaxometry Invest. Radiol. 1998, 33, 841-845 (Pubitemid 30247070)
15. 3+ Nanocrystals as Dual-Modal Contrast Agent for High Field Magnetic Resonance and Optical Imaging Chem. Mater. 2011, 23, 2439-2446
16. Elst, L. V.; Roch, A.; Gillis, P.; Laurent, S.; Botteman, F.; Bulte, J. W. M.; Muller, R. N. Dy-DTPA Derivatives as Relaxation Agents for Very High Field MRI: The Beneficial Effect of Slow Water Exchange on the Transverse Relaxivities Magn. Reson. Med. 2002, 47, 1121-1130 (Pubitemid 34587403)
17. Gossuin, Y.; Hocq, A.; Vuong, Q. L.; Disch, S.; Hermann, R. e. P.; Gillis, P. Physico-chemical and NMR Relaxometric Characterization of Gadolinium Hydroxide and Dysprosium Oxide Nanoparticles Nanotechnology 2008, 19, 475102
18. 3 (Ln = Eu, Gd, Dy, Ho, and Er) Nanoparticles as a New Potential MRI Contrast Agent ACS Appl. Mater. Interfaces 2011, 3, 3325-3334
19. Norek, M.; Peters, J. A. MRI Contrast Agents Based on Dysprosium or Holmium Prog. Nucl. Magn. Reson. Spectrosc. 2011, 59, 64-82
20. 3 Nanoparticles for Optimal Performance as an MRI Contrast Agent J. Am. Chem. Soc. 2008, 130, 5335-5340 (Pubitemid 351537093)
21. Ho, D.; Sun, X.; Sun, S. Monodisperse Magnetic Nanoparticles for Theranostic Applications Acc. Chem. Res. 2011, 44, 875-882
22. 1 MRI Contrast Enhancement Chem. Mater. 2011, 23, 3714-3722
23. Vetrone, F.; Naccache, R.; Morgan, C. G.; Capobianco, J. A. Luminescence Resonance Energy Transfer from an Upconverting Nanoparticle to a Fluorescent Phycobiliprotein Nanoscale 2010, 2, 1185-1189
24. Wang, F.; Banerjee, D.; Liu, Y.; Chen, X.; Liu, X. Upconversion Nanoparticles in Biological Labeling, Imaging, and Therapy Analyst 2010, 135, 1839-1854
25. 4 Nanocrystals J. Am. Chem. Soc. 2007, 129, 14834-14835 (Pubitemid 350230689)
26. 3+@Silica Fiber Nanocomposite Adv. Funct. Mater. 2011, 21, 2356-2365
27. Zhang, F.; Shi, Q. H.; Zhang, Y. C.; Shi, Y. F.; Ding, K. L.; Zhao, D. Y.; Stucky, G. D. Fluorescence Upconversion Microbarcodes for Multiplexed Biological Detection: Nucleic Acid Encoding Adv. Mater. 2011, 23, 3775-3779
28. Wang, G. F.; Peng, Q.; Li, Y. D. Lanthanide-Doped Nanocrystals: Synthesis, Optical-Magnetic Properties, and Applications Acc. Chem. Res. 2011, 44, 322-332
29. 4 Nanophosphors for Multimodality PET/MR/UCL Imaging Biomaterials 2011, 32, 1148-1156
30. Jun, Y.-W.; Lee, J.-H.; Cheon, J. Chemical Design of Nanoparticle Probes for High-Performance Magnetic Resonance Imaging Angew. Chem., Int. Ed. 2008, 47, 5122-5135
31. Caravan, P.; Greenfield, M. T.; Bulte, J. W. M. Molecular Factors that Determine Curie Spin Relaxation in Dysprosium Complexes Magn. Reson. Med. 2001, 46, 917-922 (Pubitemid 33019915)
32. Kato, H.; Kanazawa, Y.; Okumura, M.; Taninaka, A.; Yokawa, T.; Shinohara, H. Lanthanoid Endohedral Metallofullerenols for MRI Contrast Agents J. Am. Chem. Soc. 2003, 125, 4391-4397 (Pubitemid 36512335)
33. Rohrer, M.; Bauer, H.; Mintorovitch, J.; Requardt, M.; Weinmann, H.-J. Comparison of Magnetic Properties of MRI Contrast Media Solutions at Different Magnetic Field Strengths Invest. Radiol. 2005, 40, 715-724 (Pubitemid 41546838)
34. Wang, Y.-X. J. Superparamagnetic Iron Oxide Based MRI Contrast Agents: Current Status of Clinical Application Quant. Imaging Med. Surg. 2011, 1, 35-40